The study, Evidence of Missed Novel Psychoactive Substances (NPS) in Unexpected Fentanyl Positives, by Aegis Sciences Corporation was recognized by the AACC...
Aegis Sciences Corporation has achieved great success with its sales and service according to our latest Client Satisfaction Survey. Our...
NASHVILLE, Tenn., July 1, 2023 – Aegis is pleased to announce that following a rigorous review process, it will continue to...
Aegis recent panelist, Ryan S. Alexander, DO, MPH, has released an op-ed where he expresses the need for testing in...
Aegis provider and recent panelist, Leigh Brooks, APRN, FNP-C, has released an op-ed where she shares her firsthand experience with...
Aegis Clinical Pharmacist, Andrew Holt, Pharm.D., BCMAS, CPGx, has released an op-ed where he expresses the importance of clinical definitive...
Sign up for the Aegis Newsletter